TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels
Shengjun Hong(University of Lübeck), Lars Bertram(University of Oslo), Alberto Lleó(Hospital de Sant Pau), Michael Wittig(Christian-Albrechts-Universität zu Kiel), Johannes Streffer(University of Antwerp), Dmitry Prokopenko, Isabelle Bos(Maastricht University), Julius Popp(University of Lausanne), Kaj Blennow(Sahlgrenska University Hospital), Philip Scheltens(Amsterdam University Medical Centers), Pieter Jelle Visser(Karolinska Institutet), Betty M. Tijms(Amsterdam Neuroscience), Christine Van Broeckhoven(VIB-UAntwerp Center for Molecular Neurology), Sebastiaan Engelborghs(Vrije Universiteit Brussel), Cristina Legido‐Quigley(Steno Diabetes Centers), Pablo Martínez‐Lage(Fundacion CITA Alzheimer), Rudolph E. Tanzi(Harvard University), Ulf Andréasson(Sahlgrenska University Hospital), Jill Richardson(GlaxoSmithKline (United Kingdom)), Silvy Gabel(KU Leuven), Christopher Clark(General Atomics (United States)), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Richard Dobson(King's College London), Stephanie J. B. Vos(Maastricht University), Rik Vandenberghe(Allen Institute for Brain Science), Valerija Dobričić(University of Lübeck), Charlotte E. Teunissen(Amsterdam Neuroscience), Régis Bordet(Université de Lille), Henrik Zetterberg(University of Wisconsin–Madison), Mara ten Kate(Christian-Albrechts-Universität zu Kiel), Mikel Tainta(University of London), Daniel Alcolea(Hospital de Sant Pau), Andre Franke(Christian-Albrechts-Universität zu Kiel), Giovanni B. Frisoni(University of Geneva), Olivier Blin(Aix-Marseille Université), Gwendoline Peyratout(University Hospital of Lausanne), Kristel Sleegers(University of Antwerp), Christina M. Lill(University of Münster), Simon Lovestone(Johnson & Johnson (United Kingdom)), Olena Ohlei(University of Lübeck)
Cited by 43
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k